Quality of medical management in coronary artery disease
- PMID: 25971821
- PMCID: PMC6074575
- DOI: 10.5144/0256-4947.2014.488
Quality of medical management in coronary artery disease
Abstract
Background and objectives: Patients with coronary artery disease (CAD) are at high risk of recurrent adverse cardiac events. Such risk can be diminished through a guideline-recommend optimal medical therapy (OMT), defined as adherence to appropriate antiplatelet therapy, lipid-lowering agents, beta-blockers and angio.tensin-converting enzyme inhibitors, blood pressure < 140/90 mm Hg ( < 130/80 mm Hg in diabetics and renal disease patients), low-density lipoprotein (LDL) < 2 mmol/L, smoking cessation and aerobic physical activity, and hemoglobin (Hb) A1c < 7%. Unfortunately, preliminary data suggest a wide gap between recommended and actual practices. The study aims to estimate the rate of achieving of OMT in CAD patients in Qassim Province.
Design and settings: This observational study enrolled 207 consecutive CAD patients seen in cardiology clinic in Prince Sultan Cardiac Center in Qassim between January 2012 and May 2012.
Methods: Eligible participants were over the age of 18, with CAD documented by either noninvasive testing or by coronary angiogram. We collected the demographic, medications, laboratory, and clinical data through in-person interviews, medical records, and an electronic patient database.
Results: OMT was achieved in only 10.4% of CAD patients. The rate of achievement of target systolic blood pressure was 76.5%, target diastolic blood pressure 88%, target LDL 68%, adherence to medications 91%. Diabetes was common (64% of all patients), and only 24% of these patients achieved the target HbA1c.
Conclusion: The poor achievement of optimal medical therapy in CAD patients contributes to prevent.able mortality, morbidity, and health care costs. The observed shortcomings warrant investment in strategies to achieve OMT in these high-risk patients.
Figures
Similar articles
-
Effect of Optimal Medical Therapy Before Procedures on Outcomes in Coronary Patients Treated With Drug-Eluting Stents.Am J Cardiol. 2016 Sep 15;118(6):790-796. doi: 10.1016/j.amjcard.2016.06.050. Epub 2016 Jul 1. Am J Cardiol. 2016. PMID: 27544742
-
Patients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the EuroObservational Research Programme of the European Society of Cardiology.Cardiovasc Diabetol. 2015 Oct 1;14:133. doi: 10.1186/s12933-015-0296-y. Cardiovasc Diabetol. 2015. PMID: 26427624 Free PMC article.
-
Does pharmacologic treatment in patients with established coronary artery disease and diabetes fulfil guideline recommended targets? A report from the EUROASPIRE III cross-sectional study.Eur J Prev Cardiol. 2015 Jun;22(6):753-61. doi: 10.1177/2047487314529353. Epub 2014 Apr 1. Eur J Prev Cardiol. 2015. PMID: 24691153
-
Optimal medical management of peripheral arterial disease.Vasc Endovascular Surg. 2006 Aug-Sep;40(4):312-27. doi: 10.1177/1538574406291835. Vasc Endovascular Surg. 2006. PMID: 16959725 Review.
-
Optimal Medical Therapy for Known Coronary Artery Disease: A Review.JAMA Cardiol. 2017 Sep 1;2(9):1030-1035. doi: 10.1001/jamacardio.2017.2249. JAMA Cardiol. 2017. PMID: 28700788 Review.
Cited by
-
Saudi Heart Association Guidelines on Best Practices in the Management of Chronic Coronary Syndromes.J Saudi Heart Assoc. 2022 Nov 18;34(3):182-211. doi: 10.37616/2212-5043.1320. eCollection 2022. J Saudi Heart Assoc. 2022. PMID: 36578770 Free PMC article.
-
Cardiovascular disease in the Eastern Mediterranean region: epidemiology and risk factor burden.Nat Rev Cardiol. 2018 Feb;15(2):106-119. doi: 10.1038/nrcardio.2017.138. Epub 2017 Sep 21. Nat Rev Cardiol. 2018. PMID: 28933782 Review.
-
Protective effect of active perfusion in porcine models of acute myocardial ischemia.Mol Med Rep. 2016 Oct;14(4):3581-7. doi: 10.3892/mmr.2016.5665. Epub 2016 Aug 24. Mol Med Rep. 2016. PMID: 27573177 Free PMC article.
-
Impact of myocardial perfusion and coronary calcium on medical management for coronary artery disease.Eur Heart J Cardiovasc Imaging. 2024 Mar 27;25(4):482-490. doi: 10.1093/ehjci/jead288. Eur Heart J Cardiovasc Imaging. 2024. PMID: 37889992 Free PMC article.
-
Prevalence of lipid abnormalities and cholesterol target value attainment in patients with stable coronary heart disease or an acute coronary syndrome in Saudi Arabia.Saudi Med J. 2018 Jul;39(7):697-704. doi: 10.15537/smj.2018.7.22146. Saudi Med J. 2018. PMID: 29968891 Free PMC article.
References
-
- Smith SC, Allen J, Blair SN. AHA/ACC Guidelines for Secondary Prevention for Patients with Coronary and Other Atherosclerotic Vascular Disease: 2006 Update. Circulation. 2006;113:2363–72. - PubMed
-
- Bramlage P, Messer C, Bitterlich N, et al. The effect of optimal medical therapy on 1-year mortality after acute myocardial infarction. Heart. 2010;96:604–9. - PubMed
-
- William B, Borden WB, Redberg RF, et al. Patterns and Intensity of Medical Therapy in Patients Undergoing Percutaneous Coronary Intervention. JAMA. 2011;305(18):1882–9. - PubMed
-
- Bhatt DL, Steg PG, Ohman EM, et al. International Prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA. 2006;295(2):180–118. [AUTHOR: Please check the page range, which does not seem to be correct] - PubMed
-
- Fairman K, Matheral B. Evaluating Medication Adherence: Which Measure Is Right for Your Program. J Managed Care Pharm. 2000:499–504.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous